Mohi Uddin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mohi Uddin has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Jahirul Islam Mamun
Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chittagong, Bangladesh
4 shared publications - Hossain Rasel
Department of Pharmacy, Faculty of Biological Sciences University of Chittagong Chittagong Bangladesh
3 shared publications - Khurshida Jahan Suma
Department of Pharmacy, Faculty of Biological Sciences University of Chittagong Chittagong Bangladesh
2 shared publications - Md. Ekramul Haque Ekram
Department of Pharmacy, Faculty of Biological Sciences University of Chittagong Chittagong Bangladesh
2 shared publications - Abdul Alim
Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chittagong, Bangladesh, cu.ac.bd
1 shared publication Hasan Ahmed Apu
1 shared publication
Latest Publications
- Open Access
- 30 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (8) , e72168
Pharmacological Assessment of Calamus guruba Methanolic Extract: Multitarget Effects on Diabetes, Inflammation, Anxiety, and Depression
Calamus guruba Buch.‐Ham. (Family: Arecaceae) is a traditionally valued medicinal plant recognized for its wide range of therapeutic applications. This study was designed to evaluate the antidiabetic, anti‐inflammatory, anxiolytic, and antidepressant properties of the methanolic extract of C. guruba (MECG). Phytochemical screening of the extract was performed according to standard protocols. The antidiabetic potential was assessed using an alpha‐amylase inhibition assay. At the same time, anti‐inflammatory effects were examined using both in vitro (protein denaturation) and in vivo (carrageenan‐ and formalin‐induced paw edema) models. Anxiolytic activity was evaluated using the elevated plus maze (EPM) and hole board test (HBT), and antidepressant effects were determined through the tail suspension test (TST). MECG demonstrated potent antidiabetic activity, with an IC 50 value of 48.69 μg/mL. The extract also showed marked anti‐inflammatory effects in all tested models. MECG showed significant anxiolytic activity ( p < 0.001) in both the EPM and HBT at a dose of 400 mg/kg. Moreover, the same dose significantly decreased immobility time in the TST compared to the control group, indicating robust antidepressant‐like effects. Collectively, these findings suggest that MECG holds promise as a natural therapeutic agent for the management of diabetes, inflammation, anxiety, and depression.
- 30 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (8) , e72168
Open AccessPharmacological Assessment of Calamus guruba Methanolic Extract: Multitarget Effects on Diabetes, Inflammation, Anxiety, and Depression
Calamus guruba Buch.‐Ham. (Family: Arecaceae) is a traditionally valued medicinal plant recognized for its wide range of therapeutic applications. This study was designed to evaluate the antidiabetic, anti‐inflammatory, anxiolytic, and antidepressant properties of the methanolic extract of C. guruba (MECG). Phytochemical screening of the extract was performed according to standard protocols. The antidiabetic potential was assessed using an alpha‐amylase inhibition assay. At the same time, anti‐inflammatory effects were examined using both in vitro (protein denaturation) and in vivo (carrageenan‐ and formalin‐induced paw edema) models. Anxiolytic activity was evaluated using the elevated plus maze (EPM) and hole board test (HBT), and antidepressant effects were determined through the tail suspension test (TST). MECG demonstrated potent antidiabetic activity, with an IC 50 value of 48.69 μg/mL. The extract also showed marked anti‐inflammatory effects in all tested models. MECG showed significant anxiolytic activity ( p < 0.001) in both the EPM and HBT at a dose of 400 mg/kg. Moreover, the same dose significantly decreased immobility time in the TST compared to the control group, indicating robust antidepressant‐like effects. Collectively, these findings suggest that MECG holds promise as a natural therapeutic agent for the management of diabetes, inflammation, anxiety, and depression.
- Open Access
- 1 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (7)
Bioactivity Assessment and In Silico Target Engagement of Clerodendrum infortunatum Extracts: Correlating Experimental Outcomes With DFT and Docking Predictions
Clerodendrum infortunatum (Lamiaceae) is commonly employed in traditional healing practices to manage inflammation, fever, pain, and gastrointestinal ailments. Despite its widespread use, there is limited scientific evidence supporting these therapeutic claims and insufficient characterization of its active phytochemicals. This study aimed to investigate the anti‐inflammatory, analgesic, antipyretic, and antidiarrheal properties of the methanolic extract (MECI) and n‐hexane fraction (NHF) derived from C. infortunatum leaves through integrated in vivo and in silico methodologies. Anti‐inflammatory activity was evaluated using protein denaturation and carrageenan‐induced paw edema models; analgesic effects were assessed via acetic acid‐induced writhing and tail immersion tests; antipyretic and antidiarrheal activities were examined using yeast‐induced pyrexia and castor oil‐induced diarrhea models, respectively. Additionally, molecular docking, ADME/T (absorption, distribution, metabolism, excretion/toxicity), DFT, and PASS (Prediction of Activity Spectra for Substances) analyzes were performed to explore the pharmacokinetic profiles and potential molecular targets of the identified compounds. MECI demonstrated strong inhibition of protein denaturation (89.29%) with an IC₅₀ of 44.10 μg/mL, comparable to diclofenac sodium. Both MECI and NHF significantly attenuated carrageenan‐induced paw edema and writhing responses in a dose‐dependent manner ( p < 0.001), increased latency in the tail immersion test, and effectively reduced both yeast‐induced fever and castor oil‐induced diarrhea. In silico docking revealed that hydrocinnamic acid, o‐[(1,2,3,4‐tetrahydro‐2‐naphthyl)methyl]‐, exhibited high binding affinities for COX‐2 (−9.1) and the M 3 muscarinic receptor (−10.2 kcal/mol), while ethyl isoallocholate showed notable affinity for mPGES‐1 (−5.6 kcal/mol). ADME/T, DFT, and PASS predictions indicated favorable oral bioavailability and low toxicity for the major constituents. The findings substantiate the traditional medicinal uses of C. infortunatum , demonstrating its multi‐target pharmacological actions mediated through COX‐2, mPGES‐1, and M3 muscarinic receptor pathways. Hydrocinnamic acid derivatives and ethyl isoallocholate emerge as promising candidates for the development of new anti‐inflammatory, analgesic, and antipyretic therapeutics.
- 1 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (7)
Open AccessBioactivity Assessment and In Silico Target Engagement of Clerodendrum infortunatum Extracts: Correlating Experimental Outcomes With DFT and Docking Predictions
Clerodendrum infortunatum (Lamiaceae) is commonly employed in traditional healing practices to manage inflammation, fever, pain, and gastrointestinal ailments. Despite its widespread use, there is limited scientific evidence supporting these therapeutic claims and insufficient characterization of its active phytochemicals. This study aimed to investigate the anti‐inflammatory, analgesic, antipyretic, and antidiarrheal properties of the methanolic extract (MECI) and n‐hexane fraction (NHF) derived from C. infortunatum leaves through integrated in vivo and in silico methodologies. Anti‐inflammatory activity was evaluated using protein denaturation and carrageenan‐induced paw edema models; analgesic effects were assessed via acetic acid‐induced writhing and tail immersion tests; antipyretic and antidiarrheal activities were examined using yeast‐induced pyrexia and castor oil‐induced diarrhea models, respectively. Additionally, molecular docking, ADME/T (absorption, distribution, metabolism, excretion/toxicity), DFT, and PASS (Prediction of Activity Spectra for Substances) analyzes were performed to explore the pharmacokinetic profiles and potential molecular targets of the identified compounds. MECI demonstrated strong inhibition of protein denaturation (89.29%) with an IC₅₀ of 44.10 μg/mL, comparable to diclofenac sodium. Both MECI and NHF significantly attenuated carrageenan‐induced paw edema and writhing responses in a dose‐dependent manner ( p < 0.001), increased latency in the tail immersion test, and effectively reduced both yeast‐induced fever and castor oil‐induced diarrhea. In silico docking revealed that hydrocinnamic acid, o‐[(1,2,3,4‐tetrahydro‐2‐naphthyl)methyl]‐, exhibited high binding affinities for COX‐2 (−9.1) and the M 3 muscarinic receptor (−10.2 kcal/mol), while ethyl isoallocholate showed notable affinity for mPGES‐1 (−5.6 kcal/mol). ADME/T, DFT, and PASS predictions indicated favorable oral bioavailability and low toxicity for the major constituents. The findings substantiate the traditional medicinal uses of C. infortunatum , demonstrating its multi‐target pharmacological actions mediated through COX‐2, mPGES‐1, and M3 muscarinic receptor pathways. Hydrocinnamic acid derivatives and ethyl isoallocholate emerge as promising candidates for the development of new anti‐inflammatory, analgesic, and antipyretic therapeutics.
- 26 March 2026
- Published by Elsevier in Pharmacological Research - Natural Products
- Vol. 11
Comprehensive evaluation of the methanolic stem extracts of Etlingera linguiformis (Roxb.): Antipyretic, antioxidant, anti-inflammatory, antidiabetic, and thrombolytic activities via In Vitro and In Vivo studies
- 26 March 2026
- Published by Elsevier in Pharmacological Research - Natural Products
- Vol. 11
Comprehensive evaluation of the methanolic stem extracts of Etlingera linguiformis (Roxb.): Antipyretic, antioxidant, anti-inflammatory, antidiabetic, and thrombolytic activities via In Vitro and In Vivo studies